Multiple Myeloma Research Review, Issue 16

In this issue:

ADMYRE shows improved survival with plitidepsin plus dexamethasone for RRMM
Selinexor induces deep responses in triple-class refractory MM patients in STORM
CASSIOPEIA shows a benefit for daratumumab in transplant-eligible NDMM
Daratumumab plus carfilzomib and dexamethasone in patients with RRMM
Weekly carfilzomib dosing is safe and effective for untreated MM patients
Treatment regimens for NDMM ineligible for transplant
Supportive care utilisation in MM patients in the U.S.
Cardiac events during PI therapy for relapsed MM
Clonal evolution in myeloma
Proteolysis targeting chimeric molecules

Please login below to download this issue (PDF)

Subscribe